Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2020

Dec 11, 2020

33298_dirs_2020-12-11_df77aa49-1e6e-4dbb-8658-a4f755391bb3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2020-12-08

Reporting Person: Alvarez Nicholas P (Chief Acquisition Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-08 Options to purchase Common Stock $7.92 A 200000 Acquired Common Stock, par value $0.001 (200000) Direct

Footnotes

F1: The Options were issued to Mr. Alvarez pursuant to the terms of an amended and restated employment agreement, dated December 8, 2020 (the "Effective Date"), by and between Mr. Alvarez and the Issuer. The options shall vest at a rate of 5,555 options each month for thirty-five (35) consecutive months beginning on the Effective Date, with the final 5,575 shares vesting on December 8, 2023.